IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma
PHASE3CompletedINTERVENTIONAL
Enrollment
493
Participants
Timeline
Start Date
June 30, 2005
Primary Completion Date
January 31, 2008
Study Completion Date
June 30, 2008
Conditions
Multiple Myeloma
Interventions
DRUG
Velcade
Trial Locations (1)
44093
CHU de Nantes, Service d'Hématologie, Nantes
All Listed Sponsors
lead
Nantes University Hospital
OTHER
NCT00200681 - IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter